Post-translational modification of a chimeric EPO-Fc hormone is more important than its molecular size in defining its in vivo hematopoietic activity.
Salgado-Rojas, E., Montesino, R., Jiménez, S.P., González, M., Hugues, F., Cabezas, O.I, Maura-Perez, R., Saavedra, P.A, Lamazares, E., Salas-Burgos A., Sanchez O., Vera J.C., Toledo, J.R.